Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorYıldırım, Ayhan
dc.contributor.authorKösem, Mustafa
dc.contributor.authorSayar, İlyas
dc.contributor.authorGelincik, İbrahim
dc.contributor.authorYavuz, Alparslan
dc.contributor.authorBozkurt, Aliseydi
dc.contributor.authorBayram, İrfan
dc.date.accessioned2022-05-11T14:36:54Z
dc.date.available2022-05-11T14:36:54Z
dc.date.issued2014
dc.identifier.issn1940-5901
dc.identifier.urihttps://hdl.handle.net/20.500.11776/8474
dc.description.abstractIn the present study, the intention was to reveal the relationship of histological grade and stage with c-erbB2, CD44s, and PCNA immunoreactivity in bladder urothelial carcinomas (UC). In our study, we evaluated 46 items of transurethral resection material of patients submitted by YYU Faculty of Medicine, Main Department of Pathology, with a mass revealed in their bladder after clinical and radiological studies at our laboratories and who were diagnosed with urothelial carcinomas. PCNA, c-erbB2, and CD44s were applied in an immunohistochemical manner comprised from nine low-malignant potential papillary urothelial neoplasia, 23 low-grade papillary urothelial carcinoma, and 14 high-grade papillary urothelial carcinoma. Immunostaining was scored according to the percentage of positive cells. The immunohistochemical study demonstrated that the c-erbB2 and PCNA staining ratio increased when an increase occurred in stage and grade. The CD44s staining ratio decreased. C-erbB2, PCNA, and CD44s appear to be a useful marker in the assessment of the prognosis and treatment options in urothelial carcinomas.en_US
dc.language.isoengen_US
dc.publisherE-Century Publishing Corpen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectUrothelial carcinomasen_US
dc.subjectPCNAen_US
dc.subjectCD44en_US
dc.subjectC-erbB2en_US
dc.subjectimmunohistochemical studyen_US
dc.subjectTransitional-Cell Carcinomaen_US
dc.subjectUrinary-Bladderen_US
dc.subjectNuclear Antigenen_US
dc.subjectProtein Expressionen_US
dc.subjectGeneen_US
dc.subjectP53en_US
dc.subjectCytokeratin-20en_US
dc.subjectClassificationen_US
dc.subjectRecurrenceen_US
dc.subjectPrognosisen_US
dc.titleRelationship of PCNA, C-erbB2 and CD44s expression with tumor grade and stage in urothelial carcinomas of the bladderen_US
dc.typearticleen_US
dc.relation.ispartofInternational Journal of Clinical and Experimental Medicineen_US
dc.departmentFakülteler, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Tıbbi Patoloji Ana Bilim Dalıen_US
dc.authorid0000-0002-8497-4704
dc.authorid0000-0002-8796-988X
dc.identifier.volume7en_US
dc.identifier.issue6en_US
dc.identifier.startpage1516en_US
dc.identifier.endpage1523en_US
dc.institutionauthorGelincik, İbrahim
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.authorscopusid56260632400
dc.authorscopusid6603721364
dc.authorscopusid55945180700
dc.authorscopusid17134802600
dc.authorscopusid55682194900
dc.authorscopusid55755871000
dc.authorscopusid14622668400
dc.authorwosidErkorkmaz, Unal/B-1270-2016
dc.authorwosidYavuz, Alpaslan/H-3947-2014
dc.authorwosidErkorkmaz, Ünal/AAA-4241-2022
dc.identifier.wosWOS:000341255900004en_US
dc.identifier.scopus2-s2.0-84904036546en_US
dc.identifier.pmid25035774en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster